Mao F - Search Results

1

Intestinal mucus barrier: A potential therapeutic target for IBD.

Qiao Y, He C, Xia Y, Ocansey DKW, Mao F. Qiao Y, et al. Among authors: mao f. Autoimmun Rev. 2024 Dec 9;24(2):103717. doi: 10.1016/j.autrev.2024.103717. Online ahead of print. Autoimmun Rev. 2024. PMID: 39662652 Review.

2

The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases.

Zhao Z, Zhang L, Ocansey DKW, Wang B, Mao F. Zhao Z, et al. Among authors: mao f. Front Immunol. 2023 May 16;14:1166536. doi: 10.3389/fimmu.2023.1166536. eCollection 2023. Front Immunol. 2023. PMID: 37261347 Free PMC article. Review.

3

Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer.

Xia Y, Zhang L, Ocansey DKW, Tu Q, Mao F, Sheng X. Xia Y, et al. Among authors: mao f. Front Endocrinol (Lausanne). 2023 Oct 10;14:1242991. doi: 10.3389/fendo.2023.1242991. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37881499 Free PMC article. Review.

4

Effects of DNA methylation and its application in inflammatory bowel disease (Review).

Akanyibah FA, Zhu Y, Wan A, Ocansey DKW, Xia Y, Fang AN, Mao F. Akanyibah FA, et al. Among authors: mao f. Int J Mol Med. 2024 Jun;53(6):55. doi: 10.3892/ijmm.2024.5379. Epub 2024 May 2. Int J Mol Med. 2024. PMID: 38695222 Free PMC article. Review.

5

HucMSC-Ex alleviates DSS-induced colitis in mice by decreasing mast cell activation via the IL-33/ST2 axis.

Wei Z, Tang X, Yi C, Ocansey DKW, Mao F, Mao Z. Wei Z, et al. Among authors: mao z, mao f. Am J Transl Res. 2024 Jun 25;16(6):2727-2744. doi: 10.62347/EXZE5413. eCollection 2024. Am J Transl Res. 2024. PMID: 39006299 Free PMC article.

6

Current evidence and therapeutic implication of PANoptosis in cancer.

Ocansey DKW, Qian F, Cai P, Ocansey S, Amoah S, Qian Y, Mao F. Ocansey DKW, et al. Among authors: mao f. Theranostics. 2024 Jan 1;14(2):640-661. doi: 10.7150/thno.91814. eCollection 2024. Theranostics. 2024. PMID: 38169587 Free PMC article. Review.

7

The emerging role of the gut microbiota and its application in inflammatory bowel disease.

Wang X, Peng J, Cai P, Xia Y, Yi C, Shang A, Akanyibah FA, Mao F. Wang X, et al. Among authors: mao f. Biomed Pharmacother. 2024 Oct;179:117302. doi: 10.1016/j.biopha.2024.117302. Epub 2024 Aug 19. Biomed Pharmacother. 2024. PMID: 39163678 Free article. Review.

8

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer.

Zhou M, Wang D, Li X, Cao Y, Yi C, Wiredu Ocansey DK, Zhou Y, Mao F. Zhou M, et al. Among authors: mao f. Front Pharmacol. 2022 Oct 6;13:1016836. doi: 10.3389/fphar.2022.1016836. eCollection 2022. Front Pharmacol. 2022. PMID: 36278234 Free PMC article. Review.

9

The role of suppressor of cytokine signaling 3 in inflammatory bowel disease and its associated colorectal cancer.

Zhang P, Pei B, Yi C, Akanyibah FA, Mao F. Zhang P, et al. Among authors: mao f. Biochim Biophys Acta Mol Basis Dis. 2025 Feb;1871(2):167578. doi: 10.1016/j.bbadis.2024.167578. Epub 2024 Nov 19. Biochim Biophys Acta Mol Basis Dis. 2025. PMID: 39571630 Review.

10

The emerging role of oxidative stress in inflammatory bowel disease.

Muro P, Zhang L, Li S, Zhao Z, Jin T, Mao F, Mao Z. Muro P, et al. Among authors: mao z, mao f. Front Endocrinol (Lausanne). 2024 Jul 15;15:1390351. doi: 10.3389/fendo.2024.1390351. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39076514 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,373 results

Search Page

Filters